Eli Lilly backs crackdown on fake Mounjaro in Gurugram, flags safety risks

Authorities in Gurugram have uncovered a racket involved in the manufacturing and sale of fake Mounjaro (tirzepatide) injections – used for treating diabetes and obesity – with the arrest of two people and issued a nationwide alert to trace counterfeit batches.
Following the confiscation of counterfeit injections, pharmaceutical company Eli Lilly, the manufacturer of Mounjaro, reacted to the seizure.
“We have been made aware of a recent development in relation to the seizure of suspicious and counterfeit products that allegedly carry our product brand name Mounjaro (Tirzepatide)…Lilly takes patient safety extremely seriously and welcomes regulatory authority’s action against illicit medicines,” Eli Lilly and Company (India) spokesperson said.
Drug Control Officer Amandeep Chauhan on Monday said investigators are probing the network behind the illegal operation and tracking all those linked to the racket.
A Health Department team raided a residential society in Sector 62, Gurugram